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Initiation of gene transcription by RNA polymerase (Pol) III requires the activity of TFIIIB, a
complex formed by Brf1 (or Brf2), TBP (TATA-binding protein), and Bdp1. TFIIIB is required
for recruitment of Pol III and to promote the transition from a closed to an open Pol III pre-
initiation complex, a process dependent on the activity of the Bdp1 subunit. Here, we present
a crystal structure of a Brf2–TBP–Bdp1 complex bound to DNA at 2.7 Å resolution, integrated
with single-molecule FRET analysis and in vitro biochemical assays. Our study provides a
structural insight on how Bdp1 is assembled into TFIIIB complexes, reveals structural and
functional similarities between Bdp1 and Pol II factors TFIIA and TFIIF, and unravels essential
interactions with DNA and with the upstream factor SNAPc. Furthermore, our data support
the idea of a concerted mechanism involving TFIIIB and RNA polymerase III subunits for the
closed to open pre-initiation complex transition.
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RNA polymerase III (Pol III) is the eukaryotic multisubunitDNA-dependent enzyme dedicated to the transcription ofshort untranslated RNAs involved in essential cellular
processes, such as the entire pool of transfer RNAs, the 5S
ribosomal RNA, and the spliceosomal U6 small nuclear RNA
(snRNA).
Transcription initiation requires the action of the TFIIIB
complex, which is both required and sufﬁcient to recruit Pol III to
the promoter and to faithfully initiate transcription in yeast1. The
TFIIIB complex is composed of three subunits: the TATA-
binding protein (TBP), TFIIB-related factor 1 (Brf1), and Bdp12, 3.
In vertebrates, the TFIIB-related factor II (Brf2) replaces Brf1 at
type III promoters such as the U6 snRNA promoter, which,
unlike the other types of Pol III promoters, are characterized by
the presence of a strong TATA box and an upstream proximal
sequence (PSE) recognized by the multisubunit transcription
factor SNAPc4–6 (Fig. 1a). Although in Saccharomyces cerevisiae
and human cells the majority of Pol III promoters recognized by
the Brf1-containing complex do not have a TATA box, a TATA
box can recruit both Brf1-containing TFIIIB complexes and
Brf2-containing TFIIIB complexes2, 3. In the context of such
TFIIIB complexes, TBP recognizes speciﬁcally the TATA box
inducing a sharp bend of the DNA, whereas the TFIIB-related
factors Brf1 and Brf2, similarly to their Pol II paralog TFIIB,
recognize TATA-ﬂanking regions and interact directly with Pol
III, thus effectively bridging the polymerase to its target
promoters4, 5. While Brf1 and Brf2 interact tightly with TBP and
co-purify, the third component of the TFIIIB complex, Bdp1, is
weakly associated within the TFIIIB complex in absence of DNA
but contributes to the formation of an extremely stable
TFIIIB–DNA complex7–9. Accordingly, TFIIIB complexes have
been shown to act as genomic roadblocks that induce dissociation
of the DNA replicative machinery at lagging strands, as well as
termination of transcription derived from neighboring Pol II
transcriptional units limiting pervasive transcription10, 11. In this
context, Bdp1 appears to play an important role since Bdp1
depletion has been shown to abolish TFIIIB roadblock function10.
Bdp1 is a transcription factor unique to the Pol III system as a
Bdp1 paralog in the Pol I and Pol II system has not been iden-
tiﬁed. Bdp1 contains a highly conserved SANT domain, which
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Fig. 1 Structure of the Brf2–TBP–Bdp1–DNA complex. a Architecture of a RNA Pol III type III promoter. Numbers indicate the position of promoter elements
relative to the transcriptional start site (+1). b Schematic overview of Bdp1 proteins and variants used in this study. The black line represents the region for
which an atomic model could be built in the electron density. c EMSA showing binding of different Bdp1 constructs to Brf2–TBP–DNA complexes (last four
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constitutes the major module interacting with Brf1–TBP and
Brf2–TBP complexes12–15. The SANT domain together with the
N-terminal and C-terminal ﬂanking regions forms an extended
SANT domain, which is essential for viability in yeast (Fig. 1b)14,
16. Bdp1 has been shown to form a complex network of inter-
actions within the Pol III pre-initiation complex (PIC) and to play
an essential role in DNA strand separation during the transition
from a closed to an open form of the PIC, as transcriptionally
inactive Bdp1 mutants could be rescued by pre-opening DNA
templates in yeast16, 17. In particular, the Bdp1-extended SANT
domain is required for Pol III PIC assembly and stability16.
In the human system, several Bdp1 isoforms exist, which con-
tain C-terminal extensions of different lengths characterized by
the presence of a 55-residue repetitive motif12. Albeit important
for regulation, the human-speciﬁc Bdp1 C-terminal extension is
not strictly required for transcription, as a yeast-like human Bdp1
truncated protein is capable of faithfully initiating transcription
in vitro13. Recently, Bdp1 has been found to be essential in pro-
moting tumorigenicity in P53-mutated prostate cancers18. Despite
its central role in the assembly of TFIIIB complexes and in the
initial steps of Pol III transcription initiation, the molecular
architecture and function of Bdp1 are still poorly understood.
Here, we describe the crystal structure of a Brf2–TBP–Bdp1
complex bound to a naturally occurring DNA promoter and,
integrating the structure with single-molecule FRET and bio-
chemical analysis, unravel the central role of Bdp1 in TFIIIB
assembly and RNA Pol III PIC formation. The SANT domain of
Bdp1 interacts with both TBP and DNA, while a structured linker
emerging at the N terminus of the SANT domain interacts with
the minor groove of the DNA. Binding of Bdp1 to
Brf2–TBP–DNA complexes confers stability to TFIIIB and
provides essential binding surfaces for the upstream factor
SNAPc. Assembly of Bdp1 into a TFIIIB complex does not result
into DNA melting or destabilization, suggesting that Bdp1 might
allosterically alter Pol III-subunit conformations during the
closed to open PIC transition.
Results
Crystal structure of a human TFIIIB–DNA complex. To gain
insight into the structure and function of Bdp1 in the context of
TFIIIB complexes, we expressed and puriﬁed to homogeneity
several variants of human Bdp1 based on secondary structure
predictions and homology with the yeast protein (Fig. 1b and
Supplementary Fig. 1). A minimal construct encompassing the
conserved Bdp1-extended SANT domain (residues 241–396,
referred to as Bdp1SANT hereafter) binds to the Brf2–TBP–DNA
complex with similar afﬁnity to longer Bdp1 constructs, as shown
by electrophoretic mobility shift assays (EMSAs; Fig. 1c). This
suggests that the extended SANT domain represents the major
anchoring point of human Bdp1 within the TFIIIB complex, in
agreement with what was previously observed in yeast19.
Bdp1SANT could be crystallized by vapor diffusion in complex
with Brf2, TBP, and a DNA fragment of 25 base pairs (bp) of the
human U6 promoter (referred to as TFIIIB–DNA complex
hereafter), and the X-ray structure was solved at 2.7 Å by
molecular replacement (Table 1 and Supplementary Fig. 2). In the
TFIIIB–DNA complex (Fig. 1d), Bdp1 can be schematically
divided into a compact domain constituted by the Bdp1 SANT
domain (helix 1–3, residues 303–348) as well as two additional
C-terminal α-helices (helix 4 and 5, residues 348–382), and an
N-terminal extension that forms an ordered linker (residues
286–302). Bdp1 residues 241–285, which are predicted to form a
β-strand region and are essential for promoter opening in
yeast17, 20, and 383–396 are not visible in the electron-density
map, suggesting that in the absence of Pol III these regions are
disordered. Comparison with a Brf2–TBP–DNA structure4
reveals that, while the DNA path is only slightly altered, Bdp1
binding locally perturbs the geometry of the Brf2–TBP complex
and results in a rearrangement of the Brf2 N-terminal and
C-terminal repeats relative to TBP (Fig. 2). In particular, at the
downstream TATA-ﬂanking region the Brf2 N-terminal cyclin
fold moves away from TBP, leaving Brf2 interactions with the
template strand unperturbed but causing a shift of register of one
nucleobase on the non-template strand (Fig. 2a and Supplemen-
tary Fig. 3). This change appears to be induced by the binding of
Bdp1 to the Brf2–TBP–DNA complex, but we cannot rule out the
possibility that the different crystal packing as well as the different
DNA scaffold used in this study might additionally play a role.
Nevertheless, these data suggest that, while the DNA template
strand is held very tightly within the TFIIIB complex, the
non-template strand displays a certain degree of ﬂexibility.
Toward the end of the Bdp1 linker and at the top of the major
groove, Bdp1 S293 clashes with a phosphate group of the DNA
template strand, which is shifted away and stabilized by a strong
hydrogen bond with Bdp1 Y291, resulting in disengagement of
Brf2 Y260 at the GR element4, a DNA sequence recognized
directly by the Brf2 protein upstream the TATA box, and a
movement of the entire Brf2 C-terminal cyclin fold (Fig. 2b).
Thus, while recognition of the GR element is important for the
initial binding of Brf2–TBP complexes at Brf2-dependent
promoters, this interaction is loosened upon Bdp1 binding.
The molecular pin of Brf2, a short helical element important
for the assembly and regulation of Brf2–TBP–DNA complexes4,
is unaltered in the TFIIIB structure, suggesting that binding of
Bdp1 does not alter the redox-sensing properties of Brf2.
Bdp1SANT tripartite interaction with TBP–Brf2 and the DNA.
In the TFIIIB–DNA complex, Bdp1SANT lays at the interface
Table 1 Data collection and reﬁnement statistics
TFIIIB/DNA
Data collection
Space group P21
Cell dimensions
a, b, c (Å) 91.2, 124.1, 88.6
α, β, γ (°) 90, 99.5, 90
Resolution (Å) 49–2.7 (2.79–2.7)a
Rpim (%) 0.11 (1.13)
I/σI 5.3 (0.7)
Completeness (%) 99.2 (99.7)
Redundancy 9.2 (9.3)
CC1/2 0.988 (0.257)
Reﬁnement
Resolution (Å) 49–2.7
No. of reﬂections 431,731
Rwork/Rfree (%) 19.7/23.3
No. of atoms
Protein 9247
DNA 2124
Ligand/ion 2
Water 252
B-factors
Protein 85.1
DNA 91.5
Ligand/ion 88
Water 58.2
R.m.s deviations
Bond lengths (Å) 0.01
Bond angles (°) 1.02
Each structure was determined from one crystal
aHighest resolution shell is shown in parenthesis
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between the DNA region immediately upstream of the TATA
box, the TBP N-terminal stirrup, and the Brf2 TBP anchor
domain—the high-afﬁnity TBP-binding site at the very
C terminus of Brf24—in agreement with recent crosslinking
studies16, 21 (Fig. 1d). The observed location overlaps with the
binding site of transcription factor TFIIA in the Pol II system
(Supplementary Fig. 4)22–24. However, in contrast to TFIIA, the
Bdp1SANT establishes tight interactions not only with TBP but
also with the DNA. The recognition helix (α3, residues 334–347)
of Bdp1SANT contacts both sides of the major groove of the
DNA, using conserved polar residues to interact with the phos-
phate backbone of the template and non-template DNA strands
(Fig. 3a and Supplementary Fig. 3). In particular, the invariably
conserved Bdp1 residue R334 forms a salt bridge with TBP
residue E191, and contacts the DNA phosphate backbone of the
template strand (Fig. 3a). Highlighting the importance of this
interaction, a Bdp1 R334E mutation, which inverts the net polar
charge, reduces Bdp1 binding to the Brf2–TBP complex, as shown
by EMSAs (Fig. 3b). In agreement with this ﬁnding, the E191K
mutation in human TBP and the corresponding TBP E93R
mutation in yeast, both polar charge-inverting mutations, have
been shown to strongly reduce TFIIIB assembly and Pol III-
speciﬁc transcription25, 26. This suggests that the location of Bdp1
SANT domain is additionally conserved in Brf1-containing
TFIIIB complexes. Impacting on recruitment of Bdp1 onto the
TFIIIB complex and, consequently, on the formation of pro-
ductive Pol III PICs, the Bdp1 R334E mutation substantially
reduces the Pol III transcriptional output, as shown in an in vitro
transcriptional assay (IVT) based on a type III Brf2-dependent
promoter and recombinant factors (Fig. 3c). The residual Pol III
activity suggests, however, that redundant interactions, likely
involving SNAPc, additionally contribute to efﬁcient Bdp1
recruitment at type III promoters.
A Bdp1 linker invades the DNA minor groove. The N-terminal
region ﬂanking the Bdp1 SANT domain, which we named the
“Bdp1 linker” (residues 286–302), adopts an extended con-
formation, spanning the entire length of the minor groove of the
DNA and inserting in between the two Brf2 cyclin repeats
(Figs. 1d and 4a). The Bdp1 linker is enriched in aromatic resi-
dues, a feature that is conserved throughout evolution (Supple-
mentary Fig. 1). Bdp1 residues Y299 and F294 anchor the Bdp1
linker to the major groove of the DNA through aromatic-sugar
interactions with the DNA backbone (Fig. 4a). Bdp1 F294 buries
into a hydrophobic cavity formed by the sugar moiety of the
DNA, TBP L187, and Brf2 L146 (Fig. 4a). This interaction is likely
to be conserved throughout evolution, including yeast
Brf1-containing TFIIIB complexes, as an aromatic residue is
invariantly present in Bdp1 homologs, TBP L287 is universally
conserved and Brf2 L146 is highly conserved or invariably
replaced by a hydrophobic residue in yeast and human Brf14
(Supplementary Fig. 1).
The orientation of the Bdp1 linker relative to the SANT
domain is determined by conserved polar interactions involving
the Bdp1 R332 residue. R332 is a strictly evolutionarily conserved
residue and is held in position by E307, another highly conserved
residue, to form hydrogen bonds with two adjacent residues of
the linker (a carbonyl oxygen and a conserved Ser/Thr residue;
Fig. 4b). Additionally, R332 forms a hydrophobic stacking
interaction with the strictly conserved residue W303.
Deletion of the Bdp1 linker (residues 288–299, Bdp1 Δlinker)
results in reduced binding of Bdp1 to the Brf2–TBP–DNA
complex, as shown by EMSA (Fig. 4c), and in appreciable
reduction of transcriptional output in IVTs (Fig. 3c). In
agreement with these ﬁndings, deletion of the Bdp1 linker region
conferred lethality in yeast14. Further analysis revealed that
deletion of the Bdp1 linker (residues 409–421) caused a defect in
promoter opening on linear templates, which could only be
partially rescued by pre-opening the DNA template. In contrast,
deletion of the adjacent β-strand region resulted in a severe defect
in promoter opening that could be fully restored by pre-opening
the DNA, suggesting a major role for the β-strand region in
promoter opening27. Thus, the Bdp1 linker is an essential region
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which plays a role in promoter opening, likely by optimally
positioning the adjacent β-strand region in the Pol III PIC, but
also by having an impact on Bdp1 recruitment onto TFIIIB
complexes.
Dynamics of TFIIIB–DNA binding. In order to understand the
dynamics of the system and the relative contribution of TBP,
Brf2, and the Bdp1-extended SANT domain in the assembly of a
functional TFIIIB complex on the DNA, we employed single-
molecule FRET to follow the bending of the U6 promoter DNA
upon binding of the TFIIIB components (Fig. 5, Table 2, Sup-
plementary Fig. 5 and Supplementary Table 1). As observed for
Pol II promoters, binding of TBP to the TATA box induces the
initial bending of the DNA28, while Brf2 and Bdp1 in isolation
have no effect on DNA bending (Fig. 5b, Table 2, Supplementary
Fig. 5 and Supplementary Table 1). Human TBP induces a single
bent state of the U6 promoter (Fig. 5a), and the FRET efﬁciency
oscillates between high and low values, suggesting a rapid asso-
ciation of TBP with the DNA and subsequent rapid dissociation
(lifetime of the TBP–DNA complex= 0.29 s, Supplementary
Fig. 6a). This observation is in agreement with a previous study
that reported very short lifetimes (2–20 s) for human TBP in
complex with a canonical RNA Pol II promoter29. However, the
situation is very different in yeast, where the TBP–DNA complex
can adopt two conformations that differ in their bending angles
distinguished by an extremely high stability of the complex
(lifetime of 12 min)28.
Upon addition of TBP and Brf2 to the promoter DNA,
molecules showed that stable high FRET and washing of the
measuring chamber with only buffer did not result in loss of the
high FRET states (Fig. 5b). In contrast to what observed for
the binary TBP–DNA complex, the bend DNA molecules in the
Brf2–TBP–DNA complex showed that stable FRET and no
dynamics could be detected, a further indication that
Brf2 stabilizes the TBP–DNA interaction. Analysis of confocal
single-molecule measurements exploiting the FRET signal in
solution estimated a lifetime of slightly over 6 min (381 s) for the
Brf2–TBP–DNA complex (Fig. 5b and Supplementary Fig. 6d). It
is noteworthy that the dynamic interaction of human TBP with
the U6 promoter DNA and the stabilization of the TBP–DNA
complex by the TFIIB-like factor Brf2 is reminiscent of the highly
dynamic interaction of archaeal initiation factors TBP and TFB
with promoter DNA28.
Addition of Bdp1SANT to the Brf2–TBP–DNA complex has
no effect on the DNA-bending angle but increases the estimated
lifetime of the complex to ~9 min (547 s, Supplementary Figs. 5
and 6d and Supplementary Table 1). In support of this ﬁnding, an
EMSA competition assay, using an unlabeled competitor DNA,
conﬁrms that the addition of Bdp1SANT results in an increased
stability of the full TFIIIB complex (Supplementary Fig. 7), as
shown by relatively high level of binding of TFIIIB complexes to
labeled DNA even in presence of 200-fold excess of unlabeled
competitor. Thus, in agreement with the crystal structure,
addition of Bdp1SANT to Brf2–TBP–DNA complexes does not
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alter the bending state of the DNA, suggesting that Bdp1 binds to
the stable pre-bent Brf2–TBP–DNA complex resulting in
extremely stable complexes bound to the DNA.
Bdp1 N-terminal regions and C-terminal regions. Albeit efﬁ-
ciently recruited onto TFIIIB complexes (Fig. 1c), Bdp1SANT is
virtually inactive in IVTs (Fig. 6a). A Bdp1 construct lacking the
N-terminal region (Bdp1-ΔN) is also inactive in IVTs, while a
construct lacking the C-terminal region (Bdp1-ΔC) shows
reduced activity (Fig. 6a). This result suggests that Bdp1
N-terminal regions and C-terminal regions play an important
role in driving faithful Pol III transcription. As noted before, one
possibility is the involvement of Bdp1 terminal extensions in
binding to the essential upstream factor SNAPc. Bdp1 interacts
strongly with SNAPc in absence of DNA, as shown in pull-down
assays (Fig. 6b), as well as in presence of DNA, as shown by
EMSA (Fig. 6c). Binding of Bdp1-ΔN to SNAPc is reduced both
in the presence and absence of DNA, while Bdp1-ΔC is still able
to bind to SNAPc at appreciable levels (Fig. 6b, c). Removal of
both the N-terminal and C-terminal regions, which is the
aforementioned Bdp1SANT variant, abolishes binding to SNAPc
(Fig. 6b, c). These results closely mirror the results obtained in
IVTs, suggesting that the terminal regions of Bdp1 are capable of
binding to SNAPc and that these interactions are essential to
support RNA Pol III transcription.
A model of the Pol III PIC. During Pol III transcription
initiation, Bdp1 stimulates the transition from a closed to an open
PIC, a process that occurs without ATP hydrolysis30. The
structure presented here reveals that, in the context of an isolated
TFIIIB complex, Bdp1 does not induce DNA melting by
stabilizing ﬂipped nucleobases, as observed in bacterial
σ factors31, 32. To further investigate the role of Bdp1 in promoter
opening, we combined the TFIIIB structure presented here with
the available atomic models of Pol III33 and of a human
Pol II-PIC23 and generated a model of a Pol III-PIC (Fig. 7). The
model reveals that the Bdp1 SANT domain is distant from
the core of the polymerase, analogously to TFIIA in RNA
Pol II, contributing to the stability of the PIC23, 24. On the other
hand, after exiting the Brf2 cyclin folds the Bdp1 linker points
toward a surface formed between the protrusion and the wall
domains, an analogous location as observed for the Tfg2 linker of
TFIIF in Pol II PICs (Fig. 7), which provides additional stability to
TFIIB on the wall of Pol II23, 24. As a result, the predicted
N-terminal β-strand Bdp1 segment, which is essential for
promoter opening17, could be located in the proximity of the Pol
III protrusion, similarly to the TFIIF Tfg2 linker and Tfg1 arm,
which add β-strands to the Pol II protrusion, resulting in the
stabilization of the DNA bubble. These ﬁndings suggest that Bdp1
might stimulate DNA strand separation through an allosteric
mechanism involving RNA Pol III subunits, as previously
hypothesized17.
Discussion
The structure of the TFIIIB–DNA complex reveals how Bdp1 is
recruited onto a Brf2–TBP–DNA complex through essential
interactions, which are conserved throughout evolution. Bdp1 is
organized in a compact extended SANT domain, which repre-
sents the major Bdp1 anchor point to the Brf2–TBP–DNA
complex, and an N-terminal linker that invades the DNA minor
groove (Fig. 1c). The SANT domain binds in an analogous
location as observed for TFIIA, while the Bdp1 linker, and the
adjacent β-strand segment, might bind similarly to the Tfg2 linker
of TFIIF, according to our model of a RNA Pol III PIC. Thus,
albeit structurally unrelated, Bdp1 exploits comparable binding
surfaces and mechanisms utilized by distinct transcription factors
in the Pol II system.
Furthermore, Bdp1 strongly interacts with the upstream DNA,
on both the major and the minor groves, thus contributing to the
high stability of TFIIIB complexes on the DNA10, 15 (Figs. 1d, 3a
and 4a). Bdp1 binds efﬁciently only to pre-bent Brf2–TBP–DNA
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complexes (Fig. 5), with the recognition helix of the Bdp1 SANT
domain contacting both sides of the major groove (Fig. 3a).
Binding of Bdp1 causes a subtle rearrangement of both the N-
terminal and C-terminal cyclin repeats of Brf2, resulting in a
loosened interaction with the upstream segment of DNA around
the GR element. In contrast, the template strand in the
downstream region around the TD motif4, a DNA sequence
downstream the TATA box that is speciﬁcally recognized by Brf2
residues R110 and A108, is held tightly (Fig. 2a, b). Thus, the
TFIIIB complex displays a certain degree of plasticity, allowing
structural rearrangements during the initial stages of
transcription, without compromising the interactions with the
template strand in proximity of the transcription start site. In this
respect, the situation is somewhat reminiscent of the bacterial σ
factors, which strongly interact with both template and
non-template strands, pre-organizing the DNA to engage the Pol
active center32. However, in contrast to bacterial σ factors,
TFIIIB does not directly induce DNA melting by stabilizing
ﬂipped-out nucleobases, suggesting an indirect role of TFIIIB in
promoter opening. Accordingly, our model of a Pol III PIC
reveals structural and functional analogies between domains of
Bdp1 and Pol II general transcription factors within the Pol II
PIC, which have been recently shown to spontaneously cause
DNA opening24.
The molecular details of how Bdp1 promotes DNA melting will
require further structural investigations in the context of an intact
Pol III PIC.
Methods
Recombinant-protein expression and puriﬁcation. TBP (159–339) and Brf2
(62–419) have been expressed in Rosetta (DE3)pLysS Escherichia coli cells. TBP
and the TBP–Brf2 complex were both expressed overnight at 20 °C with 1 mM
IPTG (Isopropyl β-D-1-thiogalactopyranoside) in a TB medium. Full-length Brf2
was expressed at 30 °C for 4 h with 1 mM IPTG. Cells were grown at 37 °C until the
optical density reached 0.6 (A600), and then the temperature was reduced and
IPTG was added 30 min after. Cells were harvested by centrifugation at 4000×g (20
min at 4 °C) and the pellets stored at −80 °C. For crystallization, pellets of Brf2 co-
expressed with TBP were re-suspended in 750 mM NaCl, 10 mM imidazole, 50 mM
HEPES pH 7.9, 10% glycerol, 5 mM β-mercaptoethanol (buffer A1), supplemented
with protease inhibitors tablets (Pierce), and DNase I (20 mg/mL). Cells were lysed
through sonication and clariﬁed by centrifugation (14,000×g for 45 min at 4 °C).
The supernatant was applied onto a 5 mL HisTrap HP column (GE Healthcare)
and bound proteins were washed with 50 mL of buffer A1 supplemented with 50
mM imidazole, and then eluted with buffer B1 (buffer A1 containing 300 mM
imidazole). The salt concentration was reduced to 350 mM by diluting the sample
with buffer H1 (50 mM HEPES pH 7.9, 10% glycerol, 5 mM dithiothreitol (DTT)).
The protein samples were loaded onto a 5 mL HiTrap Heparin HP column (GE
Healthcare) and eluted with a 375 mM to 1.5 M NaCl gradient in 10 column
volumes. At this stage, the Brf2–TBP complex was dissociating and the subsequent
steps were performed to purify Brf2 in isolation. The fractions containing the
protein of interest were pooled and the N-terminal His-tag was cleaved overnight
at 4 °C with the 3 C protease. Imidazole (20 mM) was added to the sample before
loading onto a 5 mL HisTrap HP column. The ﬂowthrough was concentrated and
applied onto a Superdex 200 26/600 column (GE Healthcare). The size exclusion
chromatography was performed in a buffer containing 500 mM ammonium
acetate, 50 mM HEPES pH 7.9, 10% glycerol, and 2 mM DTT (gel ﬁltration buffer).
The fractions containing Brf2 were pooled, concentrated, ﬂash-frozen, and stored
at −80 °C. For full-length Brf2, the same protocol was used, with the exception that
the tag was not cleaved and the second nickel column step was omitted.
His-TBP pellets were re-suspended in buffer A2 (A1 buffer containing 500mM
NaCl) supplemented with protease inhibitor tablets (Pierce) and DNase I (20mg/mL).
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Fig. 5 Inﬂuence of transcription factors on promoter DNA conformation. a Single-molecule FRET measurements were carried out using a synthetic
U6 snRNA promoter. FRET between an internal donor (ATTO 532) and acceptor (ATTO 647N) dye was used as a readout to follow transcription initiation
factor-induced bending of the promoter DNA. b Measurements on immobilized molecules were conducted once with the proteins present in the ﬂow
chamber and after a washing step that removed freely diffusing proteins. A representative intensity–time trace for each measurement is shown depicting
the dynamic association and dissociation of TBP (10 nM) with and from the DNA with a complex lifetime of τ= 0.29 s. In contrast, addition of Brf2 results
in a stable complex characterized by a single high FRET state with a complex lifetime of 381 s. Addition of Bdp1SANT increased the lifetime of the high FRET
state to 547 s. FRET efﬁciency histograms show the distribution between low FRET (free DNA) and high FRET states (bend DNA). The total number of
molecules used for each histogram is given as n. Each histogram was ﬁtted with a single or double Gaussian distribution to determine the mean FRET
efﬁciencies (see Table 2). Each measurement was carried out at least three times
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Cell lysis and clariﬁcation were performed as mentioned above and the supernatant
applied on a 5mL HisTrap HP column (GE Healthcare). The bound proteins were
washed with 50mL of buffer A2 supplemented with 50mM imidazole, and then
eluted with buffer B2 (similar to buffer B1 but with 500mM NaCl). The fractions
containing His-TBP were pooled and loaded onto a 5mL HiTrap Heparin HP
column (GE Healthcare). The protein was eluted with 500mM to 2M NaCl gradient
in 10 column volumes. The tag was cleaved overnight at 4 °C by addition of the 3 C
protease. The reaction was then adjusted to 20mM imidazole and loaded onto a
HisTrap HP column. The ﬂowthrough was concentrated and loaded onto a Superdex
200 16/600 column (GE Healthcare) in gel ﬁltration buffer. After elution, the protein
was concentrated, ﬂash–frozen, and stored at −80 °C.
Bdp1-WT (residues 1–484) and Bdp1-ΔC were cloned into pOPINE vector
(uncleavable C-terminal His-tag), while Bdp1SANT and Bdp1-ΔN were cloned into
pOPINF vector (cleavable N-terminal His-tag). Proteins were expressed in
E. coli BL21-CodonPlus (DE3)-RIL cells (Agilent Technologies) in TB media. Expression
was induced when cells reached OD600= 2 with 0.5mM IPTG for 16 h at 18 °C.
Bdp1 proteins were puriﬁed from clariﬁed lysate through consecutive Ni-NTA
(Qiagen) afﬁnity chromatography. For crystallization of Bdp1SANT, the afﬁnity tag
was removed by cleavage with 3 C protease for 16 h at 4 °C with a protease/protein
molar ratio of 1:50. Further puriﬁcation of recombinant proteins was achieved
through HiTrap Heparin HP (5 mL) chromatography (GE Healthcare) and
size-exclusion chromatography (HiLoad 16/600 Superdex 200, GE Healthcare) in
50 mM HEPES pH 7.8, 500 mM Ammonium Acetate, 10% glycerol, and 2 mM
DTT. Protein samples were concentrated to 0.15 mM with VivaSpin 10,000
Daltons molecular weight cut-off centrifugal ﬁlter units (Generon) and were stored
at −80 °C after ﬂash-freezing in liquid nitrogen.
SNAPcΔ is a complex comprising subunit SNAPc190Δ (residues 1–516) with a
N-terminal Strep-tag, SNAPc50 with a N-terminal His tag, SNAPc43, and
SNAPc19. The genes were cloned in pACEBAC1 and expressed in insect cells. Hi5
cells were harvested after 4 days of infection by centrifugation at 250×g for 10 min
at 4 °C and the pellets stored at −80 °C. The re-suspension buffer is composed of
750 mM NaCl, 10 mM imidazole, 50 mM HEPES pH 7.9, 10% glycerol, 5 mM
β-mercaptoethanol (buffer A0), supplemented with protease inhibitor tablets
(Pierce) and DNase I (20 μg/mL). Cells were lysed through sonication and were
clariﬁed by centrifugation (14,000×g for 45 min at 4 °C). The supernatant was
applied onto a 5 mL HisTrap HP column (GE Healthcare) and bound proteins
were washed with 50 mL of buffer A1 (500 mM NaCl, 50 mM HEPES pH 7.9, 50
mM imidazole, 5 mM β-mercaptoethanol, and 10 mM O-Phospho-L-serine). The
complex was then eluted with a buffer containing 500 mM NaCl, 50 mM HEPES
pH 7.9, 300 mM imidazole, and 5 mM β-mercaptoethanol. The salt concentration
was reduced to 250 mM by diluting the sample with buffer H1 (50 mM HEPES pH
7.9, 10% glycerol, and 1 mM TCEP). The sample was loaded onto a 5 mL HiTrap
Heparin HP column (GE Healthcare) and eluted with a 250 mM to 1.25M NaCl
gradient in 10 column volumes. The fractions containing the protein of interest
were pooled. The N-terminal His-tags were cleaved with the 3 C protease and the
sample was dephosphorylated with the lambda phosphatase during an overnight
incubation at 4 °C. Imidazole (30 mM) was added to the sample before loading
onto a 5 mL HisTrap HP column. The ﬂowthrough was concentrated and applied
onto a Superdex 200 26/600 column (GE Healthcare). The size exclusion
chromatography was performed in a buffer containing 100 mM NaCl, 50 mM
HEPES pH 7.9, 10% glycerol, and 1 mM TCEP.
Oligonucleotides. All oligonucleotides for EMSAs and crystallography were
purchased from Integrated DNA Technologies. Each oligonucleotide (single
strand) was re-suspended in 50 mM Tris pH 8.0, 5 mM MgCl2, and 1 mM EDTA,
and was mixed with the complementary strand in an equimolar ratio, heated at
95 °C for 3 min, and then allowed to cool down to room temperature overnight.
Fluorescently labeled oligonucleotides for single-molecule FRET analysis were
purchased from IBA (Göttingen). Single-strand oligonucleotides were
re-suspended in 10 mM Tris-HCl pH 8.0, 50 mM NaCl EDTA, and mixed with the
complementary strand in an equimolar ratio, heated at 95 °C for 3 min, and then
allowed to cool down to room temperature overnight.
Crystallization, data collection, and processing. DNA sequences used for
crystallization are the following: 5′-GGTCACACCTATTTTAAGCCCTTCAAC-3′
(template strand) and 5′-TTGAAGGGCTTAAAATAGGTGTGAC-3′ (non-tem-
plate strand). Overhangs were used to stabilize the crystal packing. The complexes
were assembled at a ﬁnal concentration of 60 μM with an equimolar ratio of TBP
and Brf2, 1.1 molar excess of Bdp1SANT, and 1.2 excess of the double-stranded
DNA (dsDNA). Crystals were grown by mixing 1 μl of the complexes and 1 μl of
the crystallization solution (10–16% PEG 8000, 150–200 mM KCl, 100 mM MES
pH 6.5, 10–15 mM MgCl2, and 1 mM TCEP) in hanging drop plates. Seeds were
introduced after 16 h of equilibration. After 3 days, crystals were cryo-protected in
a mix of 50% parafﬁn/50% paratone and ﬂash-frozen in liquid nitrogen. X-ray
diffraction data consist of two data sets recorded on the same crystal after
translating the beam to a different region of the crystals. Both were collected at
0.919761 Å, with 0.02 s exposition and 0.1° oscillation, for a total of 7200 images on
beamline ID29 at the ESRF (France). The data were indexed and scaled with XDS
and XSCALE34, and merged with AIMLESS35. The data were processed using
CC1/2 and completeness as cutoff criterion36.
Structure determination and reﬁnement. The structure containing the SANT
domain was solved by molecular replacement using the TBP–Brf2–DNA structure
(PDB id: 4ROC) as a search model in PHASER37. A rigid body reﬁnement of each
of the Brf2 cyclin repeats was carried out independently, and the resulting density
maps clearly showed α-helices corresponding to the Bdp1 SANT domain. Iterative
manual building was performed with COOT38, and BUSTER-TNT (version 2.10.1)
was used for reﬁnement39. The quality of the ﬁnal structure was assessed with
MolProbity40. Data collection and reﬁnement statistics are shown in Table 1. The
ﬁnal model has excellent stereochemistry (Ramachandran allowed 99.3%). The
ﬁgures were prepared with PyMol (version 1.8.4.0 Schrödinger LLC). The align-
ments were performed with Clustal Omega41 and prepared with ESpript42.
Electrophoretic mobility shift assay. The oligonucleotides used for the
interaction of Bdp1 on the TBP–Brf2 complex are Cy-5-labeled and based on the
U6_2 sequence: 5′-Cy5-ATTTGATTGAAGGGCTTAAAATAGGTGTGA-
CAGTAACC-3′ and 5′-GGTTACTGTCACACCTATTTTAAGCCCTTCAATC
AAAT-3′. The complexes were assembled in a 20 μl reaction volume in a buffer
containing 500 mM ammonium acetate, 50 mM HEPES pH 7.9, 10% glycerol, and
1 mM TCEP. The complexes were assembled by mixing 1.5 pmol of the dsDNA
with 5 pmol of TBP (159–339), 7 pmol of Brf2 (62–419), and 10 pmol of Bdp1
construct, except stated differently. The complexes were then incubated at 21 °C for
20 min. Prior to loading the sample in the EMSA, the reactions were diluted
twofold in a buffer containing 100 mM ammonium acetate, 50 mM HEPES pH 7.9,
40% glycerol, and 1 mM TCEP. The binding reactions were resolved on a 4.5%
polyacrylamide (37.5:1 acrylamide/bis-acrylamide, 10% glycerol, Tris borate EDTA
1×) gel in 1× Tris-borate EDTA running buffer at 40 mA.
The complexes for the competition assays in Supplementary Fig. 7 were
assembled as described above, but using 15 pmol of the Bdp1SANT domain. The
complexes were assembled in presence of the labeled DNA and incubated for 20
min before adding the unlabeled competitor (same sequence). The complexes were
incubated for an hour before loading on the gel.
The oligonucleotides used to monitor the interaction between Bdp1 and
SNAPcΔ are also based on the U6_2 sequence but contain 7 bp upstream and
downstream of the PSE (speciﬁed in italic): 5′-CCATAAGTTATCCTAACCAAAA
Table 2 FRET efﬁciencies (E) and percentage of dynamic molecules for the single-molecule FRET promoter-bending essay
Protein in ﬂow chamber Standard error R² After washing Standard error R²
TBP
Elow (xc± σ) 0.22± 0.05 0.001 0.9907 0.23± 0.05 0.0003 0.9988
Ehigh (xc± σ) 0.54± 0.11 0.003 0.53± 0.12
dyn. mol. (%) 46 6
TBP–Brf2
Elow (xc± σ) 0.23± 0.06 0.002 0.9911 0.23± 0.05 0.001 0.9893
Ehigh (xc± σ) 0.56± 0.12 0.002 0.53± 0.14 0.003
dyn. mol. (%) 12 5
TBP–Brf2–Bdp1SANT
Elow (xc± σ) 0.25± 0.07 0.004 0.9869 0.23± 0.06 0.001 0.9970
Ehigh (xc± σ) 0.58± 0.10 0.002 0.55± 0.10 0.001
dyn. mol. (%) 8 5
E is shown as the mean (xc) with standard deviation (σ) and standard error of a single or double Gaussian ﬁt with the coefﬁcient of determination (R2). Samples were ﬁrst measured with the proteins in
the ﬂow chamber and again after washing away unbound proteins with buffer
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GATGATTTGA-3′ and 5′-TCAAATCATCTTTTGGTTAGGATAACTTATGG-3′.
The complexes were assembled in a 20 μl reaction volume in a buffer containing
500 mM NaCl, 50 mM HEPES pH 7.9, 20% glycerol, and 1 mM TCEP. The
complexes were assembled by mixing 10 pmol of the dsDNA with 10 pmol of
SNAPcΔ and 15 pmol of the different Bdp1 constructs. The complexes were then
incubated at 21 °C for 20 min. The binding reactions were resolved on a 4.5%
polyacrylamide (37.5:1 acrylamide/bis-acrylamide, 10% glycerol, Tris borate EDTA
1×) gel in 1× Tris- borate EDTA running buffer at 40 mA.
The gels were scanned with a Typhoon FLA 9500 and band visualization was
carried out with ImageQuanT TL version 8.1. For Supplementary Fig. 7, the mean
and standard deviation were calculated on the basis of four and two independent
experiments for TBP–Brf2 and TBP–Brf2–Bdp1SANT, respectively. The data were
plotted with GraphPad Prism 6. EMSA reactions were loaded on a sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gel, ensuring protein
qualitative and quantitative controls.
In vitro transcription assay. In vitro transcription assays were performed as
described43 with minor modiﬁcations. Tagged pol III complex, recombinant
SNAPc, and recombinant TBP, Brf2, and Bdp1 were mixed with 250 ng of poly
(dG-dC) · poly(dG-dC) and 80 ng of pU6/Hae/RA.2 construct in 2% glycerol, 5
mM HEPES (pH 7.9), 200 mM ammonium acetate, 5 mM MgCl2, 0.025 mM
EDTA, 1 mM DTT, and protease inhibitors tablets (Pierce).
Single-molecule FRET measurements. Single-molecule FRET measurements on
immobilized DNA–protein complexes were carried out in custom-built ﬂow
chambers based on fused silica slides passivated with polyethylene glycol (PEG).
Flow chambers were prepared and assembled as described before28. Brieﬂy, quartz
slides were cleaned in peroxymonosulfuric acid. Afterward, the slides and cover-
slips were sequentially sonicated with water, Helmanex, water, and methanol. The
slides and coverslips were functionalized with N-[3-(trimethoxysilyl)propyl]ethy-
lenediamine in acidic methanol, rinsed with methanol and water, and dried at
37 °C for 1 h. The slides and coverslips were coated with a methoxi-PEG/biotin-
PEG mixture for 2 h at 21 °C, and were washed with water and ﬁnally dried at 37 °
C for 2 h. The slides and coverslips were stored in evacuated tubes at −20 °C. To
prepare the ﬂow chambers, a slide and coverslip were warmed to room temperature
before opening. A piece of paraﬁlm with cut out ﬂow channels was sandwiched
between the slide and coverslip and fused together by heating the assembled ﬂow
chamber to 90 °C. Tubes for sample injection were ﬁxed with epoxy resin. The ﬂow
chambers were cleaned with 2-propanol.
For measurements the ﬂow chamber was incubated with 0.1 mg/mL
NeutrAvidin (Pierce) in TBS (125 mM Tris-HCl pH 8, 150 mM NaCl) for 5 min
and washed with 500 µL T78 (100 mM Tris-HCl pH 7.8, 60 mM KCl, 5 mM MgCl2,
0.5 mg/ml bovine serum albumin (BSA), 1% (v/v) glycerol). Afterward, the
chamber wash ﬂushed with the pre-annealed biotinylated promoter DNA
(10 pM in TBS; Fig. 5a) for 5 s and washed with 500 µL T78.
For complex formation, protein aliquots were thawed on ice and diluted
stepwise to a concentration of 1 nM (TBP) or 0.1 nM (Brf2, Bdp1) with pre-chilled
T78. Afterward, 250 µL oxygen-scavenging buffer (80 mM Tris-HCl pH 7.8, 48 mM
KCl, 4 mM MgCl2, 0.4 mg/mL BSA, 0.8% (w/v) glycerol, 1% (v/v) glucose, 2 mM
TROLOX, 7.5 U/mL glucose oxidase type VII (Sigma-Aldrich), and 1 kU/mL
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catalase from bovine liver (Sigma Aldrich)), which contained the respective
transcription factors at a ﬁnal concentration of 10 nM (TBP) or 1 nM (Brf2, Bdp1)
was ﬂushed into the chamber and incubated for 5 min. A ﬁrst set of single-molecule
FRET measurements was carried out at 20 °C in the presence of proteins in the
buffer before washing the chamber with 250 µL T78 buffer to remove unbound
proteins. Subsequently, the chamber was ﬂushed with 250 µL oxygen-scavenging
buffer and incubated for 5 min before a second set of single-molecule FRET
measurements on stable complexes was recorded. A home-built prism-type total
internal reﬂection set-up based on a Leica DMi8 inverse research microscope was
used for all measurements44. A 532 nm solid state laser (Coherent OBIS, 30 mW
power) and a 637 nm diode laser (Coherent OBIS, clean-up ﬁlter ZET 635/10,
Chroma, 50 mW power) employing alternating laser excitation (Multistream, Cairn
Research) were used to excite the ﬂuorophores45.
A Leica HC PL Apo ×63 numerical aperture (NA) 1.20 water-immersion
objective was used to collect ﬂuorescence. Fluorescence was split by wavelength
with a dichroic mirror (HC BS 640, Semrock) into two detection channels that were
further ﬁltered with a 582/75 bandpass ﬁlter (Brightline HC, Semrock) in the green
channel, and a 635 nm long-pass ﬁlter (LP Edge Basic, Semrock) in the red
detection channel. A single EMCCD camera (Andor IXon Ultra 897, EM-gain 20,
framerate 40 Hz, 400 frames) in a dual-view conﬁguration (TripleSplit, Cairn
Research) was used to record both detection channels.
The videos were analyzed employing the iSMS software46 using the programs’
default settings. Molecule spots were detected using a threshold of 100 for
ATTO532 and ATTO647N spots. FRET efﬁciencies were calculated as proximity
ratios from ﬂuorescence intensity time traces, which were corrected for background
ﬂuorescence using the average intensity of all pixels with a 2 pixel distance to the
molecule spot. For FRET efﬁciency histograms (E-histograms), all frames of
selected traces with an S-value of 0.25–0.55 were used. The resulting FRET
efﬁciency histograms shown are accumulated data from at least three independent
measurements. The FRET efﬁciency histograms were ﬁtted with either a single or
double Gaussian ﬁt to calculate the mean FRET values and standard errors. For
dwell time histograms, traces showing dynamic switching between FRET states
were ﬁtted with the vbFRET algorithm limited to two states47. All states with a
FRET efﬁciency within the full-width at half-maximum of the high FRET
population were used to calculate the dwell time histogram. The histograms of at
least three independent experiments were normalized and ﬁtted with a mono-
exponential decay function to calculate the mean dwell time in the high FRET state
(TBP bound to DNA). In order to determine the lifetime of the long-lived
TBP–Brf2 and TBP–Brf2–Bdp1SANT complexes, we performed confocal
single-molecule ﬂuorescence measurements in solution. Prior to sample loading,
chambers (Cellview slide, Greiner Bio-One) were passivated with Tris-HCl pH 8
with 2 mg/mL BSA for 10 min and washed once with T78. For complex formation,
20 pM ﬂuorescently labeled promoter DNA and 50 nM TBP–Brf2 or
TBP–Brf2–Bdp1SANT were incubated for 15 min at room temperature in T78
and 1 mM DTT. Single-molecule ﬂuorescence of diffusing complexes was detected
with a MicroTime 200 confocal microscope (Picoquant) equipped with pulsed laser
diodes (532 nm: LDH-P-FA-530B; 636 nm: LDH-D-C-640 PicoQuant/cleanup
ﬁlter: ZET635/10; Chroma). The ﬂuorophores were excited at 20 µW using pulsed
interleaved excitation. Emitted ﬂuorescence was collected using a 1.2 NA, ×60
microscope objective (UplanSApo ×60/1.20W; Olympus) and a 50 μm confocal
pinhole was used. A dichroic mirror (T635lpxr, Chroma) separated donor and
acceptor ﬂuorescence. Additional bandpass ﬁlters (donor: ff01-582/64, Chroma;
acceptor: H690/70, Chroma) completed spectral separation of the sample
ﬂuorescence. After 5 min of measuring time, 50 µg/mL heparin was added, which
traps the dissociated proteins avoiding re-binding of the proteins to the
ﬂuorescently labeled DNA. Data analysis was performed with the SymPhoTime
64 software (Picoquant). Intensity–time traces were calculated using a 1 ms
binning. Fluorescent molecule bursts were detected using a threshold of 25 counts.
An E–S histogram was calculated for every 5 min interval of the trace (t= 0
corresponding to the 5 min prior to heparin addition). The histograms were
normalized to the total number of bursts and were ﬁtted using a single or double
Gaussian ﬁt. The ratio of the high-FRET peak area vs. the total ﬁt area was plotted
over time and ﬁtted with a mono-exponential decay to determine the average
lifetime.
Pull downs. To study the interaction between the different Bdp1 constructs and
SNAPcΔ, 50 μg of Bdp1-tagged constructs were loaded onto His SpinTrap columns
(GE Healthcare) in presence or in absence of 100 μg of SNAPcΔ, in a buffer
containing 250 mM NaCl, 50 mM HEPES pH 7.9, 10 mM imidazole, 10% glycerol,
and 2 mM β-mercaptoethanol in a total reaction volume of 300 μL. The incubation
was performed at 4 °C for 2 h. The beads were extensively washed with the same
buffer supplemented with 50 mM imidazole. The proteins were eluted with 75 μl of
the binding buffer containing 300 mM imidazole, boiled, and analyzed on a sodium
dodecyl sulphate-polyacrylamide gel electrophoresis.
Data availability. Atomic coordinates and structure factors for the reported crystal
structure have been deposited in the Protein Data Bank under accession code
5N9G. All other relevant data are available from the corresponding authors.
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